IDENTIFICATION OF CELLS OBTAINED FROM BLOOD OF ONCOLOGICAL PATIENTS WITH HEMOCYTOFILTRATION

Abstract

This article presents the outcomes of our own research of the detection of circulating cells in the peripheral blood of 48 patients with oncological diseases, using hemocytofiltration. The observed circulating cells (21 cases, 43.8%) have been represented by three variants: more often in the form of “bare” atypical nuclei (76.2% cases), also single conserved tumor cells (14.3%) and large shapeless single cells, probably of non-epithelial nature (9.5%). The difficulties of identifying the obtained cells in light microscopy and technical aspects of the usage of immunocytochemical techniques have been discussed.

Keywords

circulating cells in the peripheral blood / tumor cells / hemocytofiltration / cytological research / oncological patients

References

[1] Зубцов Д.А., Зубцова Ж.И., Лавров А.В., Легченко Е.В., Аладинский В.А., Потеряхина А.В., Гольдштейн Д.В. Циркулирующие опухолевые клетки (ЦОК) при раке молочной железы: прогностическая значимость и методы выделения. Труды МФТИ. 2012; 4(3): 18-26.

[2] Ковалев А.А., Грудинская Т.В., Кузнецова Т.П., Ковалев К.А. Гетерогенность циркулирующих опухолевых клеток. Онкология. 2012; 14(2): 126-9.

[3] Christiansen J.J, Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006; 66: 8319-26. DOI: 10.1158/0008-5472.CAN-06-0410

[4] Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006; 7(2): 131-42. DOI: 10.1038/nrm1835

[5] Hayes D.F., Cristofanilli M., Budd G.T. et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin. Cancer Res. 2006; 12(14 Pt 1): 4218-24. DOI: 10.1158/1078-0432.CCR-05-2821

[6] Gaforio J.J., Serrano M.J., Sanchez-Rovira P. et al. Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int. J. Cancer. 2003; 107(6): 984-90. DOI: 10.1002/ijc.11479

[7] Giatromanolaki A., Koukourakis M.I., Kakolyris S. et al. Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse. Int. J. Cancer. 2004; 108(4): 62-7. DOI: 10.1002/ijc.11593

[8] Serrano M.J., Sánchez-Rovira P., Delgado-Rodriguez M., Gaforio J.J. Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer. Cancer Biol. Ther. 2009; 8(8): 671-5.

[9] Бжадут О.Б., Гривцова А.Ю., Тупицын Н.Н., Тюляндин С.А. Циркулирующие опухолевые клетки в крови больных местно-распространённым и диссеминированным раком молочной железы. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2007; 18(3): 19-22.

[10] Ненахова Ю.Н., Лядов В.К., Поддубная И.В. Оценка динамики циркулирующих опухолевых клеток в процессе неоадъювантной химиотерапии у больных с местно-распространённым раком молочной железы. Современная онкология. 2017; 19(3): 64-8.

[11] Григорьева В.Л. Циркулирующие опухолевые клетки как маркёры прогноза выживаемости больных раком лёгких. Сибирское медицинское обозрение. 2016; 5: 84-6.

[12] Непомнящая Е.М., Никипелова Е.А., Нистратова О.В., Новикова И.А., Водолажский Д.И., Ульянова Е.П. Параллели между циркулирующими опухолевыми клетками и некоторыми морфо-генетическими показателями при колоректальном раке. Журнал фундаментальной медицины и биологии. 2016; 2: 64-9.

[13] Riethdorf S., Soave A., Rink M. The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer. Transl. Androl. Urol. 2017; 6(6): 1090-110. DOI: 10.21037/tau.2017.09.16

[14] Li J., Fu W., Zhang W., Li P. High Number of Circulating Tumor Cells Predicts Poor Survival of Cutaneous Melanoma Patients in China. Med. Sci. Monit. 2018; 24: 324-31.

[15] Грех И.Ф., Яковлева М.П. Методы обнаружения опухолевых клеток в кровяном русле. Ленинград : Медицина. Ленингр. отд-ние; 1966.

[16] Pantel K., Woelfle U. Detection and molecular characterisation of disseminated tumour cells: implications for anticancer therapy. Biochim. Biophys. Acta. 2005; 1756(1): 53-64. DOI: 10.1016/j.bbcan.2005.07.002

[17] Balic M., Dandachi N., Hofmann G., Samonigg H., Loibner H. et al. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B. Clin. Cytom. 2005; 68(1): 25-30. DOI: 10.1002/cyto.b.20065

[18] Kaiser J. Cancer’s circulation problem. Science. 2010; 327(5969): 1072-4. DOI: 10.1126/science.327.5969.1072

[19] Kowalewska M., Chechlinska M., Markowicz S., Kober P., Nowak R. The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regar-ded as tumour-specific in activated lymphocytes. Eur. J. Cancer. 2006; 42: 2671-4. DOI: 10.1016/j.ejca.2006.05.036

[20] Ntouroupi T., Ashraf S., McGregor S. et al. Detection of circula-ting tumour cells in peripheral blood with an automated scanning fluorescence microscope. Br. J. Cancer. 2008; 99(5): 789-95. DOI: 10.1038/sj.bjc.6604545

[21] Camara O., Jorke C., Hammer U. et al. Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment. J. Cancer Res. Clin. Oncol. 2009; 135(4): 643-7. DOI: 10.1007/s00432-008-0498-8

[22] Andreopoulou E., Yang L.-Y., Rangel K. et al. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/DetectTM versus Veridex CellSearchTM system. Int. J. Cancer. 2011; 130(7): 1590-7. DOI: 10.1002/ijc.26111

[23] Kagan M., Howard D., Bendele T. et al. A Sample Preparation and Analysis System for Identification of Circulating Tumor Cells. J. Clin. Ligand Assay. 2002; 25(1): 104-10.

[24] Van der Auwera I., Peeters D., Benoy I. et al. Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br. J. Cancer. 2010; 102(2): 276-84. DOI: 10.1038/sj.bjc.6605472

[25] Tewes M., Aktas B., Welt A. et al. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res. Treat. 2009; 115(3): 581-90. DOI: 10.1007/s10549-008-0143-x

[26] Cristofanilli M. The biological information obtainable from circulating tumor cells. Breast. 2009; 18(3): 38-40. DOI: 10.1016/S0960-9776(09)70270-X

[27] Tan S., Yobas L., Lee G., Ong C., Lim C. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed. Microdevices. 2009; 11(4): 883-92. DOI: 10.1007/s10544-009-9305-9

[28] Sun Y.-F., Yang X.-R., Zhou J., Qiu S.-J., Fan J., Xu Y. Circula-ting tumor cells: advances in detection methods, biological issues, and clinical relevance. J. Cancer Res. Clin. Oncol. 2011; 137(8): 1151-73. DOI: 10.1007/s00432-011-0988-y

[29] Hayashi N., Yamauchi H. Role of circulating tumor cells and disseminated tumor cells in primary breast cancer. Breast Cancer. 2012; 19(2): 110-7. DOI: 10.1007/s12282-011-0282-5

[30] Hofman V.J., Ilie M.I., Bonnetaud C. et al. Cytopathologic Detection of Circulating Tumor Cells Using the Isolation by Size of Epithelial Tumor Cell Method. Am. J. Clin. Pathol. 2011; 135(1): 146-56. DOI: 10.1309/AJCP9X8OZBEIQVVI

[31] Paterlini-Bréchot P., Benali N.L. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007; 253(2): 180-204. DOI: 10.1016/j.canlet.2006.12.014

[32] Weinberg R.A. Twisted epithelial-mesenchymal transition blocks senescence. Nat. Cell. Biol. 2008; 10: 1021-3. DOI: 10.1038/ncb0908-1021

RIGHTS & PERMISSIONS

Eco-Vector